Strides Arcolab buys branded generic business of Bafna Pharma
Jul 21, 2014, 06:18 PM ISTNew Delhi: Drug firm Strides Arcolab will acquire a majority stake in the India-branded generics business of Bafna Pharmaceuticals for a cash consideration of Rs 48.1 crore. The two companies have signed an agreement for the